Aethlon Medical, Inc.
AEMD
$1.70
-$0.11-6.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.08M | 7.29M | 7.34M | 7.09M | 8.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.08M | 7.29M | 7.34M | 7.09M | 8.51M |
| Operating Income | -7.08M | -7.29M | -7.34M | -7.09M | -8.51M |
| Income Before Tax | -6.94M | -7.15M | -11.52M | -11.26M | -12.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.94 | -7.15 | -11.52 | -11.26 | -12.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.94M | -7.15M | -11.52M | -11.26M | -12.58M |
| EBIT | -7.08M | -7.29M | -7.34M | -7.09M | -8.51M |
| EBITDA | -6.77M | -6.97M | -7.01M | -6.76M | -8.18M |
| EPS Basic | -42.46 | -80.86 | -245.44 | -283.45 | -345.30 |
| Normalized Basic EPS | -26.36 | -50.36 | -153.14 | -176.89 | -215.81 |
| EPS Diluted | -42.46 | -80.86 | -245.44 | -283.45 | -345.30 |
| Normalized Diluted EPS | -26.36 | -50.36 | -153.14 | -176.89 | -215.81 |
| Average Basic Shares Outstanding | 881.00K | 537.80K | 322.00K | 192.30K | 147.60K |
| Average Diluted Shares Outstanding | 881.00K | 537.80K | 322.00K | 192.30K | 147.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |